A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB. (Q37245887)
Jump to navigation
Jump to search
scientific article published on 23 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB. |
scientific article published on 23 July 2013 |
Statements
1 reference
A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB. (English)
1 reference
Ramakrishnan Gopalakrishnan
1 reference
Hittu Matta
1 reference
Preet M Chaudhary
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference